New research from our lab out today 🧬🔬
Drug-resistant mesial temporal lobe epilepsy affects a large fraction of epilepsy patients and has been linked, for years, to both blood-brain barrier dysfunction and synaptic remodeling. The molecular bridge between the two has been missing in human tissue.
We now mapped it, in the same patient samples. With our neurosurgery colleagues at USC, we took fresh resected tissue from patients with drug-resistant MTLE. From each patient we sampled two regions, the epileptic hippocampus and the less affected ipsilateral temporal pole, and split each piece into two fractions: brain microvessels and a vessel-depleted postsynaptic density fraction. Quantitative proteomics on all four fractions per patient then gave us a within-patient comparison of vessel and synaptic changes.
Comparing hippocampus to temporal pole within each patient, we found:
- In the microvessel fraction (1,541 proteins, 439 differentially expressed), tight-junction and endothelial adhesion proteins were lost, pericyte markers dropped, and fibrinogen, plasminogen, complement C3 and GFAP went up, with enrichment for complement and coagulation cascades.
- In the PSD fraction (7,450 proteins, 1,881 differentially expressed), we saw the consequences of barrier leakage as protein infiltration into the parenchyma, plus disruption of pre- and postsynaptic signaling and loss of GABAergic interneurons.
- Immunohistochemistry confirmed microvascular remodeling, pericyte loss, fibrinogen extravasation, microglial activation and presynaptic marker depletion in the hippocampus.
- Ligand-receptor mapping points to a dysregulated ECM-integrin interface between vessels and parenchyma, and network-proximity analyses nominate candidate disease-modifying compounds.
Congrats and big thanks to all authors, especially to Gavin Spillard to his 1st first-author paper :)
@KECKSchool_USC @USC_ZilkhaNeuro @USC
Preprint and interactive explorer linked in the comments!